Cathie Wood's ARK Invest increased its exposure to artificial intelligence, digital assets and next-generation healthcare during the week of June 22 to 26, while reducing positions in streaming and Chinese technology companies.
ARK Invest added to several AI-related holdings, including Cerebras Systems NASDAQ:CBRS, CoreWeave NASDAQ:CRWV, Tesla NASDAQ:TSLA, Alphabet (GOOG), Palantir Technologies NASDAQ:PLTR and Amazon (AMZN). The firm also expanded its position in SpaceX NASDAQ:SPCX across multiple funds and increased investments in crypto-linked companies such as Circle Internet Group NYSE:CRCL, Coinbase Global NASDAQ:COIN, Robinhood Markets (HOOD) and Bullish (BLSH).
In healthcare, ARK Invest increased stakes in Recursion Pharmaceuticals (RXRX), Generate Biomedicines (GENB), Tempus AI (TEM), Alamar Biosciences NASDAQ:ALMR and Eli Lilly NYSE:LLY, reflecting continued interest in AI-driven drug discovery and precision medicine.
On the selling side, ARK Invest made its largest reduction in Roku (ROKU) while also trimming holdings in Alibaba Group NYSE:BABA, Baidu NASDAQ:BIDU, Absci (ABSI), Strata Critical Medical (SRTA) and Twist Bioscience (TWST) as part of its ongoing portfolio rebalancing.